Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

BioVie Inc

BIVI
1,64
-0,03 (-1,80%)
01 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/1/202523:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202523:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/1/202523:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/12/202423:20EDGAR2Form 1-A - Offering Statement [Regulation A]
03/12/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
02/12/202422:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
27/11/202421:16EDGAR2Form S-1/A - General form for registration of securities..
22/11/202423:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
21/11/202423:29EDGAR2Form S-1 - General form for registration of securities under..
13/11/202422:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202423:15EDGAR2Form 8-K - Current report
29/10/202421:15EDGAR2Form 8-K - Current report
29/10/202416:37EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/10/202411:00EDGAR2Form 8-K - Current report
25/10/202422:01EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
24/10/202422:15EDGAR2Form 8-K - Current report
24/10/202417:35EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
24/10/202415:15EDGAR2Form 8-K - Current report
22/10/202422:01EDGAR2Form 8-K - Current report
22/10/202422:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
22/10/202414:48EDGAR2Form 8-K - Current report
22/10/202403:38EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30/9/202423:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/9/202423:00EDGAR2Form DEF 14A - Other definitive proxy statements
25/9/202423:20EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
25/9/202423:02EDGAR2Form 8-K - Current report
24/9/202423:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
24/9/202422:46EDGAR2Form 8-K/A - Current report: [Amend]
24/9/202415:20EDGAR2Form 8-K - Current report
23/9/202422:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/9/202422:57EDGAR2Form PRE 14A - Other preliminary proxy statements
21/8/202403:31EDGAR2Form 8-K - Current report
06/8/202412:00EDGAR2Form 8-K/A - Current report: [Amend]
01/8/202422:41EDGAR2Form 8-K - Current report
30/7/202423:15EDGAR2Form 8-K - Current report
13/7/202400:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/7/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/6/202423:05EDGAR2Form DEF 14A - Other definitive proxy statements
12/6/202414:24GLOBEJoin BioVie’s Exclusive Live Investor Webinar and Q&A..
07/6/202423:05EDGAR2Form PRE 14A - Other preliminary proxy statements
14/5/202423:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/3/202410:45PRNUSThe Gross Law Firm Notifies Shareholders of BioVie Inc...
11/3/202422:00EDGAR2Form 8-K - Current report
11/3/202410:45PRNUSBioVie Inc. Class Action: The Gross Law Firm Reminds BioVie..
07/3/202411:45PRNUSContact The Gross Law Firm by March 19, 2024 Deadline to..
06/3/202423:10EDGAR2Form 8-K - Current report
04/3/202423:28EDGAR2Form 8-K/A - Current report: [Amend]
04/3/202423:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/3/202413:50EDGAR2Form 8-K - Current report
01/3/202423:27EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
Apertura: 1,69 Min: 1,62 Max: 1,7303
Chiusura: 1,67

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network